.png
)
13th September,2025 The Government of India has just announced a significant change that will impact the pharmaceutical and medical devices industry, effective “22nd September 2025”. Yes, you read that right—GST rates on drugs, formulations, and medical devices are being reduced,…
5th August, 2025 The Ministry of Health and Family Welfare has issued G.S.R. 513(E) dated 29th July 2025, announcing pivotal amendments to the Cosmetics Rules, 2020 under the Drugs and Cosmetics Act, 1940. These changes aim to strengthen the regulatory…
9th July, 2025 🔍 Introduction In a significant move toward the digitization of drug regulatory processes in India, the Central Drugs Standard Control Organization (CDSCO), in collaboration with the Centre for Development of Advanced Computing (CDAC), has introduced a major…
8th June 2025, During the 66th meeting of the Drugs Consultative Committee (DCC) held at CDSCO, New Delhi, a significant regulatory concern regarding the unauthorized issuance of manufacturing licenses for new drugs by certain State Licensing Authorities (SLAs) was deliberated. ⚠️…
Published on: 16th April, 2025 The Central Drugs Standard Control Organization (CDSCO) has released a crucial directive dated 11th April, 2025, addressing the unauthorized manufacture and marketing of Fixed Dose Combinations (FDCs) by pharmaceutical manufacturers in India. The notification highlights…